A simple and low
cost cloud point extraction (CPE) method was developed for the determination of
tartrazine in food samples by spectrophotometry detection at a wavelength 427.5 nm. The CPE was
performed by utilizing Tween 20 and sodium carbonate (Na 2 CO 3 ) as extractant and separation
accelerator, respectively. Fac tors that influenced CPE such as surfactant and salt concentrations, pH
and temperature were optimized in the context of extracting tartrazine from aqueous media. Under an
optimal condition, the proposed CPE was applied for the determination of tartrazine in sweets and
concentrated syrup juice, which represented food samples. A CPE UV Vis method showed linear
calibration within the range of 1 12 mg L 1 of tartrazine with a regression coefficient was 0.9957 . The limit of detection (LOD) and limit of quantifi cation (LOQ) of the method were 0.88 mg L 1 and 2.96
mg L 1 , respectively. The relative standard deviation (RSD) was found to be < 3.00 %. The amount of tartrazine found in food samples was 1.22 6.12 mg L 1 . The results showed that the proposed CPE
method was applicable for the determination of tartrazine in food samples and the tartrazine content in the food samples was permitted according to the guidelines from the European Food Safety Authority (EFSA)
Melastoma is a genus that belongs to the Melastomataceae family and consists of 50–70 species distributed around India, Southeast Asia, Australia and the Pacific Island. Numerous species of this plant show potential therapeutic purposes. This review summarizes the scientific findings on the ethnobotanical uses, phytochemistry and pharma- cological activities of Melastoma sp. The leaves of Melastoma sp. was widely used by Asian as decoction for the remedy of gastrointestinal disorder apart from root, which was consumed as juice for skin diseases, fever and pain. Majority of the scientific studies focused on M. malabathricum showing high antimicrobial activity towards selected gram-negative and gram-positive bacteria from different parts of the plant. In vitro studies showed that Melastoma sp. possessed anti-coagulant, antioxidant, antiproliferative and immunomodulatory activities. Apart from in vitro, various in vivo studies have been conducted involving methanolic leaf extracts using Sprague Dawley rats for inhi- bition of anti-ulcer, anti-nociceptive, anti-inflammatory, anti-carcinogenic and anti-diabetic activities. Flavonoids, triterpenes, tannins, saponins and steroids are the main classes of secondary metabolites identified from Melastoma sp. Kaempferol derivatives exhibited significant main constituents from the flowers and leaves using various semi polar solvent extracts. Few phytosterols were also isolated from the leaves extract albeit the absence of alkaloids. This review shows that Melastoma sp. is an important genus of Melastomataceae family, however, the phytochemical and pharmacological findings of various species in this genus are still limited, indicating a great opportunity to explore new therapeutic activities with novel bioactive constituents.
The development and application of organic based drug carrier in drug delivery system (DDSs) with greater efficacy and
fewer side effects remains a significant challenge in modern scientific and medical research. The aim of current study
was to evaluate the ability of β-cyclodextrin (β-CD) as drug delivery carrier to encapsulate Curcumin (CUR), a promising
chemotherapeutic that exhibits low aqueous solubility and poor bioavailability forming inclusion complex by kneading
method to enhance its delivery to cancer cells. Different methods and analysis such as Fourier Transform Infrared (FTIR)
spectrometer, 1
H Nuclear Magnetic Resonance (1
H NMR), X-Ray Diffraction (XRD), Scanning Electron Microscope (SEM)
and Thermo-gravimetric Analysis (TGA) were employed to approve the successful formation of the inclusion complex
where the aromatic ring of CUR has been encapsulated by the hydrophobic cavity of β-CD. UV absorption indicated that
β-CD complex with CUR with an apparent formation constant of 1.09 × 10-8mol-1dm-3. Based on the data obtained by
methylthiazole tetrazolium (MTT), β-CD showed that not only did it enhanced Curcumin delivery, but it also improved
and promoted the anti-proliferative effect of CUR during the complexation rather than CUR alone on the MCF-7 human
breast cancer cells at 24 h incubation period with IC50 lower than that of Curcumin alone. The toxicities of the β-CD-CUR
towards MCF-7 cells were also compared to the free tamoxifen, Curcumin and β-CD. This study provides a preliminary
toxicity evaluation based on β-CD-CUR inclusion complex as potential delivery system towards the selected cancer cells.